🔴 HCW Biologics is trading 10.47% down in pre-market — no verified company-specific catalyst identified

HCW Biologics is trading 10.47% down now at $2.63 after no verified September 8, 2026 company-specific catalyst was identified.

• The latest confirmed announcement was a September 2, 2026 patent allowance for HCW9302’s alopecia areata treatment claims, which does not directly explain the decline.
• Broader markets are mixed: the S&P 500 is down 0.12% and the Nasdaq Composite is up 0.28%, so macro sentiment does not clearly account for the move.